The regulatory distinction between FDA-approved and compounded formulations is real and worth discussing with your provider
Stronger weight-loss data than semaglutide
First large study of GLP-1 receptor agonists during pregnancy
Place your Canada order Proceed through the Canada ordering path for fulfillment, shipping, and next-step processing
BPC-157 In Stock $95.00 - $265.00 13 people bought today 99.67% Purity GHK-Cu In Stock $85.00 - $150.00 12 people bought today 99.76% Purity TB-500 In Stock $165.00 - $265.00 10 people bought today 99.56% Purity CJC-1295 NO DAC + IPA 5MG/5MG In Stock $125.00 - $215.00 9 people bought today 99.00% Purity Ipamorelin 10mg In Stock $125.00 8 people bought today 99.92% Purity Tri-Heal Max 45mg TB-500 25MG / BPC-157 10MG / KPV 10MG In Stock $450.00 7 people bought today 99.00% Purity BATCH TRANSPARENCY Every retatrutide batch, individually verified We don't publish one COA per compound and call it a day
The seven drugs that are currently considered GLP-1 receptor agonists include: Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) Exenatide extended-release (Bydureon) Exenatide (Byetta) Semaglutide injection (Ozempic, Wegovy) Semaglutide tablet (Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) If all of these drugs influence GLP-1 in similar ways, what makes each of them unique
